MetLife Investment Management, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$3,057,027
-26.4%
113,771
-2.3%
0.02%
-22.6%
Q2 2023$4,151,252
+38.2%
116,412
-1.6%
0.03%
+40.9%
Q1 2023$3,004,719
-37.5%
118,296
-0.2%
0.02%
-42.1%
Q4 2022$4,809,564
+21.3%
118,579
-1.1%
0.04%
+11.8%
Q3 2022$3,963,488
-6.7%
119,924
-0.6%
0.03%
-2.9%
Q2 2022$4,248,298
-23.2%
120,656
+0.4%
0.04%
-5.4%
Q1 2022$5,528,780
-2.3%
120,217
+40.9%
0.04%
-22.9%
Q4 2021$5,657,114
+5.3%
85,326
-0.9%
0.05%
-4.0%
Q3 2021$5,374,349
-26.3%
86,086
-2.2%
0.05%
-27.5%
Q2 2021$7,288,823
+20.3%
88,008
-3.7%
0.07%
+21.1%
Q1 2021$6,060,800
-17.9%
91,401
-5.0%
0.06%
-24.0%
Q4 2020$7,382,117
+70.3%
96,209
-4.4%
0.08%
+59.6%
Q3 2020$4,333,601
-4.1%
100,641
-3.8%
0.05%
-7.8%
Q2 2020$4,518,624
+57.2%
104,622
+4.7%
0.05%
+24.4%
Q1 2020$2,875,101
-53.3%
99,934
+3.1%
0.04%
-35.9%
Q4 2019$6,151,188
+432.9%
96,976
+136.8%
0.06%
+392.3%
Q3 2019$1,154,253
+6.3%
40,9600.0%0.01%
+8.3%
Q2 2019$1,085,440
+44.4%
40,9600.0%0.01%
+50.0%
Q1 2019$751,616
+47.7%
40,9600.0%0.01%
+33.3%
Q4 2018$508,723
-35.2%
40,9600.0%0.01%
-25.0%
Q3 2018$785,203
+41.0%
40,9600.0%0.01%
+14.3%
Q2 2018$557,00040,9600.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders